Delivery Order SPE2DB22D1106-SPE2DB25FFFC2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,647.60 on August 14, 2025, for the supply of Herceptin 150 mg vials, with a completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,114.52. This firm fixed-price delivery order was competitively awarded without set-asides on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,334.70 contract is for the supply of Herceptin Hylecta 600mg-10,000 5ml, a specialty pharmaceutical product, with a completion date of February 15, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- The Defense Logistics Agency awarded a $22,138 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg vials of the cancer drug Herceptin. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceuticals and medical supplies to DOD and other federal agencies. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 7, 2023 to support DOD's mission to provide quality healthcare services to...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Herceptin 150 mg vials, a monoclonal antibody used in cancer treatment. This firm fixed-price delivery order, valued at $2,670.42, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 18, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,560.56, is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 27, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,583.08, is for the delivery of 4,568,175,562 units of the prescription drug Herceptin 150 mg vials. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $26,704.20 firm-fixed-price contract is for the delivery of HERCEPTIN 150 MG VIALS, a medical supply. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, was awarded a $26,505.90 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide HERCEPTIN 150 MG VIALS. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen's primary vehicle for delivering...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFC2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,605.30 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Herceptin Hylecta 600mg injectable medication (10,000 5ml units). This firm fixed-price delivery order, which has no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The award represents a competitive procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. This delivery order is issued under the company's $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX contract through December 2026), which enables the supply of pharmaceuticals and medical products to support Department of Defense healthcare programs globally. As a prime contractor under this comprehensive pharmaceutical support vehicle, AmerisourceBergen demonstrates capability to meet federal medical procurement requirements through open competition, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 8/25/25 |